Published by Coherent Market Insights
Posted on September 21, 2021
5 min readLast updated: February 4, 2026
The cardiac implant market is set to grow at a CAGR of 11.6%, reaching $83.7 billion by 2026, driven by technological advancements.
Cardiac implants are devices that are implanted in the heart tissue, in order to control irregular heart function. Cardiac implants such as pacemakers, defibrillator implants, and cardiac rhythm monitoring implants are available in the market to treat cardiac dysfunction such as heart rhythm disorders, arrhythmias and other heart related disorder. These cardiac implants are majorly prescribed to patients with heart failure. Cardiac implants have been developed with innovative technical features in recent years which has improved quality of life in patients with heart failure.
For instance, technologically advanced cardiac implants such as HeartWare HVAD Pump (HeartWare), Parachute Ventricular Partitioning Device (CardioKinetix Inc.), and Quadra Assura MP (St. Jude Medical, Inc.) are currently available in the market. Thus, technological advancements in implantable cardiac devices is propelling the cardiac implant market growth.
Request sample copy of this report:
https://www.coherentmarketinsights.com/insight/request-sample/1176
Increasing focus of manufacturers on development and introduction of highly advanced implantable devices aimed at improving patient outcome, is expected to drive growth of the cardiac implant market. For instance, in April 2016, St. Jude Medical, Inc. launched the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) in the U.S market. The company was later acquired by Abbott in January 2017.
Moreover, regulatory approvals for cardiac implantable devices is expected to drive growth of the cardiac implant market. For instance, in April 2016, the U.S. Food and Drug Administration approved the first pacemaker, Micra Transcatheter Pacing System, developed by Medtronic Plc Plc. The system does not require wired leads to establish an electric connection between the pulse-generating device and the heart. The device functions like a pacemaker to regulate heart rate. The device is implanted directly in the right ventricle chamber of the heart.
Detailed Segmentation
By Device Type:
By Application:
By End User:
Cardiac Implants Market by Geography Analysis::
North America (The US, Canada, and Mexico)
Europe (the UK, Germany, France, and Rest of Europe)
Asia Pacific (China, India, and Rest of Asia Pacific)
Latin America (Brazil and Rest of Latin America)
Middle East & Africa (Saudi Arabia, the UAE, South Africa, and Rest of Middle East & Africa)
Get PDF brochure of this report:
https://www.coherentmarketinsights.com/insight/request-pdf/1176
Key Players In Cardiac Implants Market
The “Global Cardiac Implants Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Medtronic Plc. BIOTRONIK, Inc., Boston Scientific Corporation, Abbott Laboratories, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC, and Qinming Medical, and Cordis Inc.
The study objectives of this report are:
• To study and analyze the global Keyword size (value and volume) by the company, key regions/countries, products and application, history data from 2020 to 2027, and forecast to 2027.
• To understand the structure of Keyword by identifying its various sub-segments.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• Focuses on the key global Keyword manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis, and development plans in the next few years.
• To analyze the Keyword with respect to individual growth trends, future prospects, and their contribution to the total market.
• To project the value and volume of Keyword sub-markets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies
Frequently Asked Questions
What are the key factors driving Cardiac Implants Market expansion?
What will be the value of Cardiac Implants Market during 2020- 2027?
Which region will make notable contributions towards global Cardiac Implants Market revenue?
What are the key players leveraging Cardiac Implants Market growth?
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Cardiac Implant Market Growth to register a CAGR of 11.6% tto cross USD 83.7 Billion By 2026 appeared first on Gatorledger.
The article discusses the growth of the cardiac implant market, projected to reach $83.7 billion by 2026.
Technological advancements and regulatory approvals are key drivers of market growth.
Major players include Medtronic, Abbott, and Boston Scientific Corporation.
Explore more articles in the Research Reports category
